Study of Aritinercept in Patients With Generalized Myasthenia Gravis
Part of paid clinical trials in Altamonte Springs, Florida.
- Sponsor
- Aurinia Pharmaceuticals Inc.
- Study ID
- NCT07596901
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
- Myasthenia Gravis, Generalized
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Aritinercept — DRUGFor subcutaneous injection
- Placebo — OTHERFor subcutaneous injection
Study Details
This clinical study will enroll patients with generalized myasthenia gravis (gMG). The goal of this clinical study is to assess the safety, tolerability, effectiveness, pharmacokinetics (how the body processes the drug) and pharmacodynamics (how the drug affects the body) of aritinercept.
Key Dates
- Start date
- Apr 22, 2026
- Status verified
- May 2026
- Primary completion
- Mar 2, 2029
- Completion
- Mar 2, 2029
Study Design
- Enrollment
- 81 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: AritinerceptDouble-Blind Treatment Period: Aritinercept by subcutaneous injection Open-Label Treatment Period: Aritinercept by subcutaneous injection
- Placebo Comparator: PlaceboDouble-Blind Treatment Period: Placebo by subcutaneous injection Open-Label Treatment Period: Aritinercept by subcutaneous injection
Primary Outcome Measure
To assess the safety and tolerability of aritinercept: Incidence of treatment-emergent adverse events [ Time Frame: Baseline to study completion, up to 73 weeks ]
Central Contacts
- Aurinia Clinical Trials Information833-606-5975
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Aurinia Investigational Site | Altamonte Springs | Florida | 32714 | |
| Aurinia Investigational Site | Boca Raton | Florida | 33487 | |
| Aurinia Investigational Site | Miami | Florida | 33173 |
Find similar trials in Altamonte Springs, FL
Related Studies
- A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia GravisPHASE2 · Recruiting · Vertex Pharmaceuticals Incorporated · Boca Raton, Florida
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin
- Myasthenia Gravis Foundation of America Global MG Patient RegistryRecruiting · Myasthenia Gravis Foundation of America · Westborough, Massachusetts
- Multi-Modal Monitoring of Disease Symptoms in Myasthenia GravisNot Yet Recruiting · BioSensics · Boston, Massachusetts